Two-stage, self-cycling process for the production of bacteriophages by Sauvageau, Dominic & Cooper, David G
RESEARCH Open Access
Two-stage, self-cycling process for the production
of bacteriophages
Dominic Sauvageau, David G Cooper
*
Abstract
Background: A two-stage, self-cycling process for the production of bacteriophages was developed. The first
stage, containing only the uninfected host bacterium, was operated under self-cycling fermentation (SCF)
conditions. This automated method, using the derivative of the carbon dioxide evolution rate (CER) as the control
parameter, led to the synchronization of the host bacterium. The second stage, containing both the host and the
phage, was operated using self-cycling infection (SCI) with CER and CER-derived data as the control parameters.
When each infection cycle was terminated, phages were harvested and a new infection cycle was initiated by
adding host cells from the SCF (first stage). This was augmented with fresh medium and the small amount of
phages left from the previous cycle initiated the next infection cycle. Both stages were operated independently,
except for this short period of time when the SCF harvest was added to the SCI to initiate the next cycle.
Results: It was demonstrated that this mode of operation resulted in stable infection cycles if the growth of the
host cells in the SCF was synchronized. The final phage titers obtained were reproducible among cycles and were
as good as those obtained in batch productions performed under the same conditions (medium, temperature,
initial multiplicity of infection, etc.). Moreover, phages obtained in different cycles showed no important difference
in infectivity. Finally, it was shown that cell synchronization of the host cells in the first stage (SCF) not only
maintained the volumetric productivity (phages per volume) but also led to higher specific productivity (phage per
cell per hour) in the second stage (SCI).
Conclusions: Production of bacteriophage T4 in the semi-continuous, automated SCF/SCI system was efficient and
reproducible from cycle to cycle. Synchronization of the host in the first stage prior to infection led to
improvements in the specific productivity of phages in the second stage while maintaining the volumetric
productivity. These results demonstrate the significant potential of this approach for both upstream and
downstream process optimization.
Background
The number of important applications for bacteriophages
and their viral particles are increasing. While phage ther-
apy was identified and initially heralded as the main
application for phages [1-4], its large scale use has yet to
materialize. However, in recent years, renewed interest is
obvious in not only phage therapy [5-8], but also in
detection and diagnostics [9-11], bacterial control [12-17]
and recombinant protein production [18-20]. Moreover,
bacteriophages have now been identified as important
tools in many aspects of nano-medicine - such as phage
display for treatment or drug discovery, gene or drug
delivery or even in direct cancer treatment [21-30].
These developments have led to the re-evaluation of the
potential uses of bacteriophages and to attempts to
improve the methods of production.
Phages are normally produced in batch fermentations
with both the advantages and inconveniences associated
with this mode of operation. The phage titers obtained
are elevated [31,32] and there are no issues with resi-
d e n c et i m eo rc o n t r o ls t r a t e g i e s .H o w e v e r ,a sw i t ha l l
batch processes, it requires a lot of manpower, large
footprints and significant capital costs. As well, the pro-
portion of downtime to production time can be high
and this limits the throughput. In general, this mode
operation is neither cost-efficient nor time-efficient. * Correspondence: david.cooper@mcgill.ca
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process, different strategies have been developed for con-
tinuous production of phages. Studies have been
conducted in chemostats [32-35] and in two-stage con-
t i n u o u sp r o c e s s e si nw h i c ht h eh o s ti sg r o w ni naf i r s t
stage and fed to a second stage where the phage is being
produced [32,34,36,37]. These processes allow high volu-
metric throughputs with smaller fermenter footprints.
However, these modes of operation have also proven to
have many disadvantages and limitations. One of the
main issues is the difficulty in maintaining a stable, con-
sistent, continuous system for the production of phages.
Such a situation is only possible if a fine balance among
the rate of phage production, the flow rate (and dilution
rate) and the rate of host proliferation is maintained
[32,34]. These systems are also highly dependent on the
threshold population density for the maintenance of the
infection [32]. Not only does this balance of rates render
the process extremely sensitive to minute disturbances -
creating difficulties in the control strategy and affecting
the robustness of the systems - but the threshold popula-
tion density is often much lower than the host densities
observed in batch processes, resulting in low phages titers
at the outlet [32,37,38]. Other issues often encountered
in continuous processes are related to the residence time
distribution [32,37]. As is the case in all continuous stir-
red-tanks, some host and phage particles will leave the
fermenter immediately upon entrance while others may
theoretically remain in the fermenter for an infinite
amount of time. The first situation leads to the harvest of
uninfected or non-lysed host cells, which lowers the volu-
metric productivity of phages. The second situation can
lead to coevolution of host cells and phages. This is often
observed in chemostats - in fact, chemostats are often
used to study the co-evolution of host/phage systems
[39-45]. The two-stage continuous systems limit to a cer-
tain extent, but do not eliminate, co-evolution [32,34].
It is possible to capitalize on the advantages of both
batch (high phage titers, robustness) and continuous
(high volumetric throughput, reduced downtime per
production time) processes using the appropriate semi-
continuous process. Examples of such processes have
been reported for insect cells/baculovirus systems
[46-48]. The present study focuses on the development
of a cycling (semi-continuous), automated, two-stage
process for the production of bacteriophages. The pro-
cess developed consists of two independently-controlled
stages. The first stage, in which the host cells are grown,
was operated under the principles of self-cycling fer-
mentation (SCF) [49]. SCF is a non-steady state, auto-
mated, cycling process in which a control parameter
l i n k e dt oc e l lg r o w t h( e . g .d i s s o l v e do x y g e no rC E R )i s
used in a feedback control loop to trigger cycling once
growth has ended. Just before the cell population enters
stationary phase, half of the contents of the fermenter
are removed and replaced by fresh medium. This has
the double advantage of both keeping the population in
exponential growth and synchronizing the population
[50-54]. The second stage, in which the host is infected
by the phage, was also operated in an automated cycling
mode termed self-cycling infection (SCI) which, to some
extent, resembles serial transfer infections [55]. The
Escherichia coli/Bacteriophage T4 system was used as a
model system to demonstrate the feasibility and implica-
tions of the system on the production of a lytic phage.
Methods
Bacterium, Phage and Medium
The present study was conducted with the bacterium
Escherichia coli ATCC 11303 and the bacteriophage T4,
ATCC 11303-B4. Cultures to be used as inocula were
grown overnight at 37°C and 250 rpm in an incubator-
shaker (New Brunswick G25, New Brunswick, NJ) to a
cell density of approximately 2 × 10
9 cfu·mL
-1.
The mineral salt medium used was described in a pre-
vious study [56]. Glucose (Sigma-Aldrich) was used as a
carbon source at a concentration of 3 g·L
-1 in the cul-
tures used as inocula, in the batch infection, in all cycles
of the SCI and in the initial cycle of the SCF. The glu-
cose concentration of the added medium used for the
subsequent SCF cycles was 6-g·L
-1.
Optical Density, Viable Cell Density and Phage Titer
Measurements
Optical density of samples from both stages of the pro-
cess was measured at a wavelength of 600 nm using a
spectrophotometer (Varian, Cary Bio 50).
Viable cell counts were performed for samples from
the SCF stage. The samples were diluted in series and
10-µL drops were spread on plates composed of 1.5%w/
v agar and 30 g·L
-1 tryptic soy broth. Plates were incu-
bated overnight at 37°C and colonies were counted. The
viable cell density was reported as colony forming units
per ml (cfu·ml
-1).
Measurements of free phage concentration were per-
formed using a technique derived from the double layer
method described by Maniatis et al.[ 5 7 ] .T h em e t h o d
was described in a previous study [56]. Filtered samples
(0.2µm syringe-filter) were diluted and 10µL drops were
placed on soft agar containing E. coli.P l a t e sw e r ei n c u -
bated overnight at 37°C. Plaques were then counted and
the phage titer was reported as plaque forming units per
ml (pfu·ml
-1).
Fermenters and Equipment
The set-up of the combined SCF/SCI process is shown in
Figure 1 and includes the control connections necessary
for cycling. The sensors, heaters and valves from both
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control and automation program was developed using
LabView®. Samples were taken from sampling ports for
analyses of cell density, OD600 or phage titer.
The SCF stage used in the present study was based on
a previously described SCF set-up [54]. The only notable
change made was the addition of an outlet (controlled
by a valve) which allowed liquid to be passed directly to
the second stage. This was equipped with an in-line iso-
lator to avoid the infection of the host cells in the first
stage by phages from the second stage. The operating
conditions for the 1-L working volume were agitation:
200 rpm, temperature: 37°C and aeration: 0.5 vvm (kLa
of 0.93 min
-1). The carbon evolution rate (CER) was
measured using an IR-spectrometry CO2 gas sensor
(CO2-BTA, Vernier, Georgetown, ON) located after an
in-line HEPA-filter at the air outlet of the fermenter.
The units of CER were mol CO2·L
-1·h
-1. As was the case
in the previous study, the rate of change of the CER was
used as the control parameter in the feedback control
loop to determine the optimal time to trigger cycling.
Two electro-optic sensors (ELS-900 series, Gems Sen-
sors) - placed at 1L and 0.5L - and current-activated
valves were used to control the volume exchanges dur-
ing cycling.
The fermenter used for the SCI stage was identical to
the one described above with one important exception.
Three electro-optic sensors were used for level control.
The first was placed at 1L, the second at 0.04L and the
third was placed at different volumes before the start of
the process. The position of the third level sensor was
set to allow the desired amount of phages to be left in
the fermenter at the end of the cycles. Aeration was
kept at 0.4 vvm (kLa of 0.84min
-1), slightly lower than in
the SCF stage. This ensured that the pressure was lower
in the second vessel and prevented, along with the in-
line isolator, phages from infecting the first cycle. Tem-
perature and agitation were the same as in the SCF
stage. The value of the CER and its rate of change were
used as the control parameters to determine the end of
the infection process and the proper time for cycling.
Batch Infection
Batch infections were performed in the SCI stage fer-
menter. In such a case, the monitoring equipment
(CER) and conditions (agitation, aeration) remained
the same but the control system was not used because
there was no cycling. The infections were started with
4×1 0
10cfu and phages were added to the desired
initial MOI.
SCF/SCI Operation
It is important to specify that, while both stages were
controlled with the same control unit (computer and
software), the system could be considered as decoupled.
Each stage operated independently. However, it was
necessary to have communication for the short period
when the SCI was cycling, when it was necessary to sup-
ply this tank with a harvest from the SCF.
The SCF stage was inoculated with 4 × 10
10cells. The
first cycle was grown as a normal batch until the condi-
tions for cycling were met. At his point, half the con-
tents of the vessel (0.5L) were removed to either a
harvest vessel or the second stage, as required. Fresh
medium was then added until the working liquid
volume was recovered (1L), starting the next cycle. The
cycling procedure was performed and a new cycle was
started every time the conditions for cycling were met.
The SCI stage was inoculated with 4 × 10
10 host cells
mixed with a phage stock to obtain the desired initial
MOI. When the infection of the first SCI cycle was ter-
minated (conditions for cycling were met), the following
sequence of events was performed: 1) the contents of
Figure 1 Schematic of the self-cycling fermentation/self-cycling
infection apparatus. Level sensors are used for the control of
valves (low: LLS, mid: MLS, high: HLS). The carbon dioxide sensors
(CERS) are used to measure CER and as the feedback control
parameter for cycling of both stages. The temperature control loops
and sampling ports are not shown.
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the lowest level sensor of this stage was triggered; 2) the
SCI stage was allowed to wait until the next SCF cycle
was ready to harvest; 3) at this point, host cells were
added to the SCI until a volume of 0.08L (corresponding
to an inoculum of approximately 1.2 × 10
11cells) was
reached (mid-level-sensor of the SCI stage triggered); 4)
any residual harvest from the SCF stage was sent to a
harvest vessel until the low-level sensor of the SCF stage
was triggered; 5) fresh medium was fed to refill the SCF
stage to 1L (high-level sensor of the SCF stage was trig-
gered); 6) the new SCF cycle was started; 7) fresh med-
ium was added to the SCI stage until the high-level
sensor (1L) of the SCI stage was triggered; 7) the new
SCI cycle was started.
T h es o u r c eo fp h a g e sf o rt h ei n f e c t i o no fe a c hS C I
cycle was the volume left in the SCI from the previous
S C Ic y c l ea tt h ee n do fs t e p1d e s c r i b e da b o v e .T o
obtain the desired initial MOI, the volume left was
determined by the height of the lowest level sensor.
This was adjusted prior to the beginning of operation. It
was also possible to include rinsing cycles before step 2
to reduce the phage concentration and MOI if desired.
Shake Flask Experiments
Shake flask experiments were also performed to investi-
gate different aspects of the infections including host/
phage interactions. A 0.4-mL aliquot of a suspension of
the host cells, containing approximately 8 × 10
8cells,
obtained from shake flasks or from the SCF/SCI system,
was mixed with 0.4-mL of a phage stock solution with a
titer adjusted to obtain the desired initial MOI. The
mixture was allowed to sit for 5 minutes to ensure
adsorption before being added to a 500-mL shake flask
containing 100 mL of medium. The shake flask was
then placed in an incubator-shaker at 37°C and 250
rpm. Samples were taken periodically to measure the
OD600 and/or the phage titer.
Results
Figure 2a shows the patterns of OD600 and carbon diox-
ide evolution rate (CER) for a batch infection of E. coli
by phage T4 at an initial MOI of 0.001. (The vessel was
the same as that used as stage 2 during the production
process.) The OD600 trend shows an initial increase as
the host cells proliferated. A maximum was seen at 5 h
after which the OD600 decreased until 8.2 h, indicating
population-wide lysis. The CER trend shows an initial
increase similar to that of OD600. However, the maxi-
mum was observed earlier, at 3 h, and the decrease was
o v e rb y7 . 8h .F i g u r e2 bs h o w st h er a t eo fc h a n g eo f
CER - measured as the slope of the CER data (calcu-
lated over 15 minute periods) - as the infection pro-
ceeded. The values were positive up to 3.8 h after which
the CER decreased and the rate of change became nega-
tive. When the infection process ended, at 8 h, the rate
of change of CER returned to zero.
Figure 3 shows the CER data for an experiment that
demonstrates operation of the SCF/SCI system. After
synchrony had been established in the SCF
( F i g u r e3 a ) ,c y c l e s5a n d1 0w e r eu s e dt oc h a r g et h e
SCI vessel for cycles 1 and 2, respectively (Figure 3b).
The initial cell load and initial MOI of each infection
cycle were 1.2 × 10
11 cfu and 0.001, respectively.
Figure 3c shows the data for the initial and final titers
of each SCI cycle.
Figure 4 shows operation of the SCF and SCI systems
for which both series were started at the same time
using an asynchronous host population. The first infec-
tion cycle of the SCI stage was started with an MOI of
0.08. The subsequent infection cycles had an initial cell
load of 1.2 × 10
11 cfu and an initial MOI of approxi-
mately 0.1. After the first SCI cycle, subsequent cycles
were started with a charge from the SCF harvest so that
SCF cycles 1, 3 and 4 were used to inoculate SCI cycles
2, 3 and 4 respectively.
Figure 2 E. coli culture infected by bacteriophage T4 in a
batch. The CER (full line) and optical density at 600 nm (■) are
shown in (a). dCER (dashed line) is shown in (b).
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starts to stabilize by the third cycle as the system tends
towards synchrony. Figures 4b and 4c show the CER
and OD600 patterns of the four SCI cycles. The duration
of cycle 1 was 4.25 h, while it was 3.8 h ± 0.1 for cycles
2 to 4. While the CER and OD600 patterns of these
cycles are all similar, they show a decrease in magnitude
with each new cycle. It can be seen that the total area
under the curve for each new cycle decreased for both
the OD600 and CER data. The final phage titer of each
infection cycle is shown in Figure 4d.
Experiments were performed to determine if cycling
had a significant effect on the virulence of phages.
Figure 5 shows results from such an experiment per-
formed with phages harvested from each of the four
SCI cycles shown in Figure 4. Phages from each of
these SCI cycles were used to infect 8 × 10
9cfu of
E. coli at an MOI of 0.05 in shake flasks. All infections
were performed at the same time, using the same con-
ditions and using samples from the same host culture
a si n o c u l a .S i n c et h es a m p l i n gw a sd o n eo n c ee v e r y
hour, some of the important features of the infections,
such as the onset of lysis inhibition, cannot be readily
identified. However, it can be seen that the four shake
flask infections had exactly the same trend and the
population-wide lysis was observed between 3 h and
4 h in all cases.
Shake flasks experiments were performed to compare
the infection of asynchronous and synchronized host
populations. The populations were taken from end-of-
cycle harvests during SCF operation. The asynchronous
population was taken at the end of a SCF cycle 1 in
Figure 3 while the synchronized population was har-
vested at the end of cycle 10. (This number of cycles
has been shown to be more than sufficient to establish
synchrony [54].) All flasks were infected under the same
growth conditions, using the same phage stock, initial
cell loads (8 × 10
9 cfu) and initial MOI (0.01). Figure 6
shows the OD600 and titer data for one of these
Figure 3 Operation of SCF/SCI system with the SCI stage
started once synchrony is established in the SCF stage. The CER
(full line) data of the SCF stage (first stage) and of the SCI stage
(second stage) are shown in (a) and (b) respectively. The phage titer
in the SCI stage (●) is shown in (c). The cycle numbers are shown
for each cycle for their respective stage.
Figure 4 Operation of SCF/SCI system with both stages started
at the same time. The CER (full line) data of the SCF stage (first
stage) and of the SCI stage (second stage) are shown in (a) and (b),
respectively. The OD600 (■) and the phage titer (●) in the SCI stage
are shown in (c) and (d), respectively. The cycle numbers are shown
for each cycle for their respective stage.
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tion of the synchronized population led to smaller
OD600 values and a shorter period of infection. How-
ever, the titer remained similar for both types of
populations.
Two approaches were taken to assess the productivity
of the system. Since OD600 can be used as an approxi-
mation of the cell concentration - in the case of infec-
tions, these two parameters are not proportional
throughout the infection process [58] - the first
approach was to approximate the specific productivity
as the phage titer at the end of a SCI cycle divided by
the integral of the OD600 data of that cycle. The units
are pfu·mL
-1·AU
-1·h
-1 a n dt h i sn u m b e ri sa ne s t i m a t i o n
of pfu·cell
-1·h
-1 or phages produced per cell per hour. In
the second approach, the integral of the CER data of the
SCI stage was used to obtain a phage productivity based
on the amount of CO2 released (final phage titer divided
by the integral of the CER data of a SCI cycle). The
units are pfu·mol of CO2
-1. The values of productivity
and final phage titer for the SCI cycles shown in Figures
3 and 4 are collected in Table 1. No significant differ-
ences in productivity or final phage titer are seen among
the cycles in Figure 3. However, while the cycles from
Figure 4 show stable final titers there are increases in
productivity with each cycle. Both measures of produc-
tivity are significantly greater for cycle 4 compared to
cycle 1.
The results of OD600-derived specific productivity for
infections carried in shake flasks with asynchronous and
synchronized cultures are also shown in Table 1. It can
be seen that the specific productivity was increased by
30% for the infection of a synchronous population rela-
tive to the asynchronous samples.
Discussion
A problem with the application of self-cycling fermenta-
tion (SCF) has been that the original control strategy
required a dissolved oxygen control that was susceptible
to fouling. It has recently been demonstrated that car-
bon dioxide evolution rate (CER) data can also be used
as the control parameter to trigger cycling and automate
the SCF process [54]. A SCF modified in this way is the
first stage in the process being investigated here and
this showed the expected stable SCF synchronized
growth pattern (Figure 3a).
This paper demonstrates that a similar control strat-
egy based on CER can be used to control a second stage
Figure 5 OD600 during batch infections of E. coli infected by
bacteriophage T4 harvested from different SCI cycles. Four
infections were initiated in shake flasks with 8 × 10
9cells at an initial
MOI of 0.05. The phages used were harvested from SCI cycles 1 (□),
2(◊), 3(Δ) and 4 (○).
Figure 6 Infections of asynchronous and synchronized E. coli
populations by bacteriophage T4. Infections were initiated in
shake flasks with 8 × 10
9 cells at an initial MOI of 0.01. OD600 (a)
and phage titer (b) are shown for asynchronous (■, ▲) and
synchronized (□, Δ) host cell populations.
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allows bacteriophages to infect host bacteria transferred
from the SCF stage. Using both the CER measurements
and the rate of change of the CER (dCER) data, it was
possible to pinpoint the end of the population-wide lysis
in the SCI, which corresponds to the end of the period
of phage release. The importance of considering both
parameters can be seen in Figure 2 at about 8 h, at
which time the value of the CER has returned to its
initial value and dCER is at 0. The d CER is a more pre-
cise control point but the first time that this parameter
passed 0 was actually the point of maximum respiration
and much too early to harvest the SCI; so both criteria
must be met. As can be seen in Figures 3b and 4b, the
control strategy was effective, robust and did not require
a probe in direct contact with the cultures.
Operation and performance of the SCF/SCI system
For a given MOI, the final phage titers obtained with
t h eS C F / S C Is y s t e mw e r eo ft h es a m eo r d e ro fm a g n i -
tude as those from batch productions performed with
the same conditions. For example, the phage titer
obtained from the SCI cycles of Figure 3c averaged
1.45 × 10
10pfu·mL
-1, while a batch infection initiated
and performed under the same conditions yielded a
phage titer of 2 × 10
10pfu·mL
-1. However, when using
the SCF/SCI system, this production could be repeated
indefinitely with no down time between harvests. This
semi-continuous harvest at a high phage titer is an
important advantage when compared to the low titers
obtained in a continuous process [32,37,38].
The advantage over batch production was increased by
the observation that the duration of each cycle in SCI
operation was actually shorter than the time required for
the infection in a comparable batch process. For example,
the first cycle in Figure 4 is, in fact, a classical batch pro-
duction and this lasted 4.25 h compared to 3.8 h for the
later SCI cycles. Another example is seen in Figure 6.
The infection performed with synchronized host cells
was shorter than that with the asynchronous population.
In fact, the productivity of the system could be
enhanced even more. The set-up used here had only a
single SCI chamber and the infection cycles can be
longer than the host generation cycle once stable opera-
tion is achieved, as shown in Figure 3. This is easily
remedied by using harvests of host cells from a single
SCF stage to provide sequentially for the required num-
ber of SCI chambers - thus optimizing the overall
process.
I ti si m p o r t a n tt on o t et h a tt h eS C Fa n dS C Is t a g e s
were controlled and operated separately and these only
needed to be coupled for a short period during cycling of
the SCI stage. This allowed both the production of the
host bacterium and its infection to be optimized sepa-
rately. Reducing the interaction between the two stages
also increased stability of operation relative to two-stage
continuous production [32]. Typically, in the latter, the
fates of both stages are closely intertwined and a distur-
bance in the feed flow rate, dilution rate or outlet flow
rate or of conditions such as temperature, pH, growth
rate or infection rate in just one stage will have a critical
impact on both stages. This often leads to the termina-
tion of the process. In contrast, both stages of the SCF/
SCI system operate independently and a disturbance in
one cycle will not necessarily be compounded by interac-
tion with the other stage or, if severe enough, force a
shut-down of both stages. In fact, the robust nature of
the SCF control allows for the system to recover from
disturbances within a few cycles as seen in Figure 3 for
cycles 6 and 7 and in earlier work [51,54].
Productivity during SCF/SCI operation
Some important information regarding the average
phage productivity in the SCF/SCI system can be
obtained by looking at the transient behaviour observed
when the system is being operated before the SCF stage
Table 1 Multiplicities of infection and phage productivity for different experiments
Experiment Multiplicity of Infection Productivity
pfu·mL
-1·AU
-1·h
-1 pfu·mol CO2
-1
SCF/SCI (Figure 3)
Cycle 1 0.01 - 7.59 × 10
14
Cycle 2 0.01 - 7.00 × 10
14
SCF/SCI (Figure 4)
Cycle 1 0.08 4.33 × 10
9 7.71 × 10
13
Cycle 2 0.1 8.97 × 10
9 2.11 × 10
14
Cycle 3 0.1 6.98 × 10
9 1.61 × 10
14
Cycle 4 0.1 9.15 × 10
9 3.17 × 10
14
Shake flasks (Figure 6)
Asynchronous host population 0.01 2.05 × 10
10 -
Synchronous host population 0.01 2.68 × 10
10 -
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traces in Figure 4 demonstrate such an operation. The
host population in the first SCF cycle had not yet
achieved synchrony. In general, five SCF cycles were
required for synchrony to be fully developed in the host
population [54]. This means that the series of host
populations used to inoculate each SCI cycle in Figure 4
had the same cell density but not the same degree of
cell synchrony.
The first important observation is that even though
each SCI cycle was inoculated with the same amount of
host cells, the integrals of OD600 and of CER - which
are both correlated to the overall integrated cell density
- decreased with each cycle. The overall trends thus
show that fewer cells were produced and less CO2 was
released in SCI cycle n+1 relative to SCI cycle n. This
means that either the trend towards synchronization of
the host population or changes in the phage population
caused a limitation of the host cell proliferation. Surpris-
ingly, despite these trends, there was no significant
change in the most important parameter, the final
phage titer (Figure 4d). It is important to note that
these transient trends were not observed for SCI cycles
performed once the host cell synchrony was fully devel-
oped in the SCF stage (e.g. Figure 3).
Three hypotheses were investigated to explain these
phenomena. The first two, which can be eliminated, are
commonly seen in continuous infection processes such
as chemostats. These were that the process selected for:
1) more virulent phages or 2) host cells that were more
susceptible to the phage. It will be shown that instead
the phenomena can be explained by the fact that 3) syn-
chronization led to an increase in the specific productiv-
ity (phage per cell per hour), which is a consequence of
burst size.
The cycling nature of the process could create a selec-
tive pressure for more virulent phages because the infec-
tion of every new cycle was initiated with phages from
the previous SCI cycle. In turn, this increasing virulence
would result in an increase in the rate of infection,
while the rate of host cell proliferation would remain
constant. This, in turn, would result in shorter infection
cycles and the amplification of the more virulent phages
with each cycle. Because host cells would have less time
to proliferate before being infected (lower OD600 and
CER), each new cycle would be faster and eventually a
decrease in final titer would be observed. However, the
increase in virulence can be dismissed. As stated above,
with fewer host cells produced, the final phage titer
would also decrease proportionally. This was not the
case and the same final titer (volumetric productivity)
was maintained throughout the cycles of the experiment
( F i g u r e4 d ) .M o r e o v e r ,a ss e e ni nF i g u r e5 ,w h e nb a t c h
infections were performed in shake flasks with phages
harvested from each of the SCI cycles seen in Figure 4,
no obvious differences were observed. The fact that the
dynamics of infection were similar means that the rate
of infection was also similar in all four cases. If the viru-
lence was drastically different in one cycle compared to
the others, the corresponding trends in Figure 5 would
have shown shorter infection times and the OD600
would have been lower. These factors showed that there
was no significant increase in virulence from one harvest
to the next over the duration of the experiments
performed.
An increase in susceptibility of the host cells could
have also explained the trends in Figure 4. However,
this can also be discounted. Again, an increase in sus-
ceptibility would have led to a decrease in the phage
titer at the end of the cycles, which was not observed.
More importantly, the SCF/SCI process could not cause
selection of more susceptible hosts because the first
stage was isolated from the SCI stage and the hosts
were always grown in the absence of phages prior to
being infected. This demonstrates an important advan-
tage of the decoupled nature of the system - it limits
the possibility of co-evolution.
As can be seen from the specific productivity results
in Table 1, after the first SCI cycle in Figure 4, there is
a noticeable increase in both measures of phage pro-
ductivity for the subsequent cycles. Since both the
OD600 and the CER data indicated that the total
amount of cells produced decreased with each subse-
quent cycle but that the volumetric productivity
remained constant, it follows that the specific produc-
tivity of the host cells (phages per cell per hour) must
have increased with each cycle. Since the specific pro-
ductivity can be used as a comparative indication of
the burst size, it can be inferred that the burst size
increased with each cycle as the synchrony of the host
population was increasing.
To test this last hypothesis, experiments were per-
formed in shake flasks with asynchronous and synchro-
nized host populations infected with the same phage
stock. This eliminated any possibility of differences due
to other factors. These experiments showed that infect-
ing synchronized populations led to less host prolifera-
tion and shorter infection times but equivalent final
titers (volumetric productivity) (Figure 6). These are the
same patterns seen in the SCF/SCI process (e.g.F i g -
ure 4). In fact, the specific productivity of the synchro-
nized population was found to be greater than that of
asynchronous populations (Table 1). Thus, the increase
in specific productivity/burst size could be explained by
the synchronization of the host cells.
Rabinovitch et al. [59] have shown, by infecting syn-
chronous E. coli cells - obtained with a “baby-machine” -
by phage T4 at different times in the cell growth cycle,
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older, larger cells. In their study, the authors did not
report a difference in the burst size between synchro-
nous and asynchronous cells. However, in the present
study, the cells are not only synchronous (all cells at the
same stage of the cell cycle) but synchronized (forced
into synchrony by the cycling process) and it has been
shown that the synchronization of E. coli cultures by
SCF affects the metabolism of the cell (e.g. by lowering
the doubling time) [54]. The implied increase in specific
productivity seen here could then be explained by a lar-
ger cell size (due to the culture always being in expo-
nential growth) and by the effects of synchronization.
A study on the effect of synchronization on the intracel-
lular processes and parameters involved in the infection
of E. coli by bacteriophage T4 (e.g.burst size, lysis time,
lysis inhibition) is currently underway.
A situation in which the volumetric productivity is
maintained while the specific productivity is increased
is obviously advantageous. Operating the SCF/SCI sys-
tem would have concrete and significant impacts on
both the up-stream and the down-stream processes
because it would be possible to obtain a higher phage
yield per operating volume, which makes the produc-
tion cheaper and more labour-efficient. The results
presented here also show that synchronized host cells
will yield more phages per cell so that fewer cells are
required to obtain a given titer. Therefore, the propor-
tion of cell debris (membrane, host proteins, etc.) to
phages would be reduced, facilitating the recovery of
the phages and lowering the costs associated with
downstream processing.
Conclusions
Production of bacteriophage T4 using the SCF/SCI pro-
cess has been shown to have many advantages over
both batch and continuous production methods. The
system provided semi-continuous harvests, which
reduced the proportion of down-time relative to produc-
tion time. Each harvest had titers at least as high as
those from batch infections carried out under similar
conditions. The independent operation of both the first
and second stages reduced the chances of co-evolution
and there was no evidence for the selection of either
more susceptible hosts or for more virulent phages.
The synchronization of the host cell populations in
the SCF stage improved the specific phage productivity
of the host cells in the SCI stage. This resulted in a
reduction of the time of infection and the yield, as indi-
cated by integrating OD600 or CER, when compared to
batch infections. The use of the SCF/SCI system can
reduce the process time and the costs associated with
both the upstream and downstream processes.
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